» Articles » PMID: 37874983

Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes

Abstract

Objective: Diabetes may feature impaired insulin kinetics, which could be aggravated by altered hepatic metabolism and glycemic control. Thus, we examined insulin clearance and its possible determinants in individuals with recent-onset diabetes.

Research Design And Methods: Participants of the German Diabetes Study (GDS) with type 1 diabetes (T1D) (n = 306), type 2 diabetes (T2D) (n = 489), or normal glucose tolerance (control [CON]) (n = 167) underwent hyperinsulinemic-euglycemic clamps for assessment of whole-body insulin sensitivity (M value) and insulin clearance (ICCLAMP). Insulin clearance rates were further calculated during intravenous glucose tolerance tests (ICIVGTT) and mixed-meal tests (ICMMT). Hepatocellular lipid content (HCL) was quantified with 1H-MRS.

Results: Both T1D and T2D groups had lower ICCLAMP (0.12 ± 0.07 and 0.21 ± 0.06 vs. 0.28 ± 0.14 arbitrary units [a.u.], respectively, all P < 0.05) and ICMMT (0.71 ± 0.35 and 0.99 ± 0.33 vs. 1.20 ± 0.36 a.u., all P < 0.05) than CON. In T1D, ICCLAMP, ICIVGTT, and ICMMT correlated negatively with HbA1c (all P < 0.05). M value correlated positively with ICIVGTT in CON and T2D (r = 0.199 and r = 0.178, P < 0.05) and with ICMMT in CON (r = 0.176, P < 0.05). HCL negatively associated with ICIVGTT and ICMMT in T2D (r = -0.005 and r = -0.037) and CON (r = -0.127 and r = -0.058, all P < 0.05). In line, T2D or CON subjects with steatosis featured lower ICMMT than those without steatosis (both P < 0.05).

Conclusions: Insulin clearance is reduced in both T1D and T2D within the first year after diagnosis but correlates negatively with liver lipid content rather in T2D. Moreover, insulin clearance differently associates with glycemic control and insulin sensitivity in each diabetes type, which may suggest specific mechanisms affecting insulin kinetics.

Citing Articles

Aberrant STING activation promotes macrophage senescence by suppressing autophagy in vascular aging from diabetes.

Ding H, Zhang Q, Yang R, Fu L, Jiang H, Zhu Q iScience. 2025; 28(1):111594.

PMID: 39834861 PMC: 11742833. DOI: 10.1016/j.isci.2024.111594.


Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.

Nadeau K, Arslanian S, Bacha F, Caprio S, Chao L, Farrell R Diabetologia. 2024; 68(3):676-687.

PMID: 39706874 DOI: 10.1007/s00125-024-06327-w.


Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1.

Aldroubi B, Najjar J, Youssef T, Rizk C, Abuamreh B, Aramouni K Metab Target Organ Damage. 2024; 4(4).

PMID: 39640841 PMC: 11619085. DOI: 10.20517/mtod.2024.48.


The relationship of changes in insulin demand and insulin adequacy over the life course.

Zhang Y, Tam C, Lau E, Ng N, Yang A, Fan B Diabetologia. 2024; 68(3):526-536.

PMID: 39611962 PMC: 11832617. DOI: 10.1007/s00125-024-06328-9.


Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis.

Sabatini S, Sen P, Carli F, Pezzica S, Rosso C, Lembo E Cell Rep Med. 2024; 5(11):101820.

PMID: 39566466 PMC: 11604487. DOI: 10.1016/j.xcrm.2024.101820.


References
1.
Ohashi K, Komada H, Uda S, Kubota H, Iwaki T, Fukuzawa H . Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans. PLoS One. 2015; 10(12):e0143880. PMC: 4666631. DOI: 10.1371/journal.pone.0143880. View

2.
Polonsky K, Gumbiner B, Ostrega D, Griver K, Tager H, Henry R . Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes. 1994; 43(7):871-7. DOI: 10.2337/diab.43.7.871. View

3.
. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2020; 44(Suppl 1):S15-S33. DOI: 10.2337/dc21-S002. View

4.
Najjar S, Caprio S, Gastaldelli A . Insulin Clearance in Health and Disease. Annu Rev Physiol. 2022; 85:363-381. DOI: 10.1146/annurev-physiol-031622-043133. View

5.
Szendroedi J, Saxena A, Weber K, Strassburger K, Herder C, Burkart V . Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol. 2016; 15:59. PMC: 4823856. DOI: 10.1186/s12933-016-0374-9. View